Japan COVID Patient Receives World's 1st Living Donor Lung T
Now open: Certificate Course in Management of Covid-19 by Govt. Of Gujarat and PlexusMDKnow more...Now open: Certificate Course in Management of Covid-19 by Govt. Of Gujarat and PlexusMDKnow more...
Get authentic, real-time news that helps you fight COVID-19 better.
Install PlexusMD App for doctors. It's free.
Kyoto University Hospital has performed the world's first living donor lung transplant on a patient who lost functionality of both her lungs due to infection from the novel coronavirus. The operation, which took around 11 hours to perform, transplanted part of the healthy lungs from the patient's husband and son to replace her failing lungs.

Both donors are in stable condition, and the patient, who is currently in intensive care, is expected to be discharged in two months if all goes well, the hospital said. After it was determined that the woman, in this case, had no hope of recovery and only a lung transplant could save her life, her husband and son offered to donate part of their lungs.

The surgery went ahead after both acknowledged the risk of decreased lung capacity on their part. There are usually restrictions on who can undergo such transplants based on age and physical condition, with the operation limited to the elderly and those with underlying illnesses in the case of damage from COVID-19.

The woman's husband and son have expressed gratitude and joy over the successful lung transplant, the hospital said. The woman had no pre-existing medical conditions but her respiratory function deteriorated rapidly after she was infected with the coronavirus at the end of last year. She developed pneumonia and that caused both her lungs to harden and shrink, destroying most of their functionality.

The hospital deemed that the infection risk to medical staff had sufficiently decreased after at least two months had passed since she received a negative result in a polymerase chain reaction, or PCR, test. The woman was admitted to the hospital while connected to an artificial heart-lung device known as extracorporeal membrane oxygenation, or ECMO, and underwent a transplant two days later.

Dr. S●●●●●●A R●Y and 12 others like this6 shares